Chen Y T, Boyer A D, Viars C S, Tsang S, Old L J, Arden K C
Department of Pathology, Cornell University Medical College, New York, NY 10021, USA.
Cytogenet Cell Genet. 1997;79(3-4):237-40. doi: 10.1159/000134734.
CTAG was initially cloned from an esophageal squamous cell carcinoma cDNA expression library by immunoscreening with autologous patient's serum. CTAG mRNA is expressed in a proportion of human cancers in a lineage-nonspecific fashion, whereas its expression in normal tissues is restricted to testis and ovary only. This expression pattern suggests that the CTAG product (NY-ESO-1) is an aberrantly activated tumor antigen and can potentially be an antigenic target for tumor vaccination. In the present study, we isolated human genomic clones of CTAG and established its genomic organization. By somatic cell hybrid studies and fluorescence in-situ hybridization, we localized this gene to chromosome Xq28, a region that also contains members of MAGE, a gene family that encodes several immunogenic tumor antigens with the characteristic cancer/testis expression pattern.
CTAG最初是通过用自体患者血清进行免疫筛选,从食管鳞状细胞癌cDNA表达文库中克隆出来的。CTAG mRNA以谱系非特异性方式在一定比例的人类癌症中表达,而其在正常组织中的表达仅局限于睾丸和卵巢。这种表达模式表明CTAG产物(NY-ESO-1)是一种异常激活的肿瘤抗原,并且有可能成为肿瘤疫苗接种的抗原靶点。在本研究中,我们分离了CTAG的人类基因组克隆并确定了其基因组结构。通过体细胞杂交研究和荧光原位杂交,我们将该基因定位到Xq28染色体,该区域还包含MAGE家族成员,MAGE是一个基因家族,编码几种具有特征性癌/睾丸表达模式的免疫原性肿瘤抗原。